BMO keeps ‘Outperform’ on TrueBlue stock, highlights sector recovery By Investing.com
On Monday, BMO Capital Markets sustained their Outperform rating on TrueBlue (NYSE:TBI) stock, with a consistent price target of $13.00.… Read More »BMO keeps ‘Outperform’ on TrueBlue stock, highlights sector recovery By Investing.com